Diesslin Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
4,228
-440
-9% -$103K 0.41% 18
2026
Q1
$1.14M Sell
4,668
-782
-14% -$182K 0.51% 17
2025
Q4
$1.13M Buy
+5,450
New +$1.08M 0.45% 21

Other funds holding JNJ

Diesslin Group's JNJ Position: Q2 2026 in Review

Diesslin Group reduced its Johnson & Johnson (JNJ) stake by 9.4% in Q2 2026, selling an estimated $103K and leaving 4,228 shares worth $1.07M. The position accounts for 0.41% of the portfolio, ranked #18.

Diesslin Group first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.14M in Q1 2026. 4,650 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Diesslin Group held 4,228 shares of Johnson & Johnson worth $1.07M as of Q2 2026.
  • Diesslin Group sold 440 Johnson & Johnson shares in Q2 2026, an estimated $103K.
  • Johnson & Johnson made up 0.41% of Diesslin Group's portfolio in Q2 2026, its #18 holding.
  • Diesslin Group first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • Diesslin Group's Johnson & Johnson position peaked at $1.14M in Q1 2026.
  • 4,650 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Diesslin Group's 13F filing for Q2 2026, filed 2 Jul 2026.